Generalized linear mixed effects models were used to compare the low carnitine status with normal carnitine group in patient measures of body mass index, seizure frequency and severity, number of anti-seizure medications, beta-hydroxybutyrate, triglyceride, and carnitine levels across baseline, 39-month follow-up (timepoint 1), 1-2-year follow-up (timepoint 2), and 2+ year follow-up (timepoint 3)
ALC is a highly bioavailable form of L-Carnitine that can cross the blood-brain barrier, where it helps to manage oxidative damage, supports mitochondrial function and helps to maintain normal neurotransmitter activity
For injectable GLP-1s specifically, this means sterile manufacturing environments, precision equipment, and the assembly of autoinjector devices that must meet quality standards
The staff are very knowledgeable and friendly